Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer.

Inna Chen, Christian Dehlendorff, Benny Vittrup Jensen, Per Pfeiffer, Jon K. Bjerregaard, Astrid Zedlitz Johansen, Svend Erik Nielsen, Fahimeh Andersen, Niels Henrik Hollander, Mette K. N. Yilmaz, Louise Skau Rasmussen, Julia S. Johansen

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind36
Udgave nummerSuppl. 4
Sider (fra-til)267
Antal sider1
ISSN0732-183X
DOI
StatusUdgivet - 1. feb. 2018
Begivenhed2018 Gastrointestinal Cancers - San Francicso, USA
Varighed: 18. jan. 201820. jan. 2018

Konference

Konference2018 Gastrointestinal Cancers
LandUSA
BySan Francicso
Periode18/01/201820/01/2018

Bibliografisk note

Gastrointestinal Cancers Symposium, San Francisco, CA, JAN 18-20, 2018

Citationsformater

Chen, I., Dehlendorff, C., Jensen, B. V., Pfeiffer, P., Bjerregaard, J. K., Johansen, A. Z., Nielsen, S. E., Andersen, F., Hollander, N. H., Yilmaz, M. K. N., Rasmussen, L. S., & Johansen, J. S. (2018). Prognostic value of serum interleukin-6 and YKL-40 and systemic inflammatory response in patients with unresectable pancreatic cancer. Journal of Clinical Oncology, 36(Suppl. 4), 267. https://doi.org/10.1200/JCO.2018.36.4suppl.267